Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Predictors of biomarkers guiding targeted therapeutic strategies in locally advanced lung cancerFrancesca Cottini, Tim LautenschlaegerExpert Review of Anticancer Therapy|May 25, 2016
MicroRNAs in non-small cell lung cancer invasion and metastasis: from the perspective of the radiation oncologistVivek Verma, Tim LautenschlaegerClinical Lung Cancer|February 2, 2021
Feasibility of Performing Transvascular Endobronchial Ultrasound-Guided Transbronchial Needle AspirationRami Naaman, Tim Lautenschlaeger, Khalil DiabExpert Review of Anticancer Therapy|June 10, 2016
Undetected lymph node metastases in presumed early stage NSCLC SABR patientsAlberto Cerra-Franco, Khalil Diab, Tim LautenschlaegerPlatelets|February 14, 2019
Platelet count correlates with stage and predicts survival in melanomaSaleh Rachidi, Maneet Kaur, Tim Lautenschlaeger, et al.Radiation Research|February 11, 2017
Blood-Based Nucleic Acid Biomarkers as a Potential Tool to Determine Radiation Therapy Response in Non-Small Cell Lung CancerChristopher R Deig, Marc S Mendonca, Tim LautenschlaegerMedical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 12, 2018
The dosimetric differences in calculating lung SBRT plans on different image data sets: Comparison of the free breathing scan to both the average intensity projection scan and to the sum of calculations on each respiratory phase of the 4DCT scanFrancesco Gaetani Liseo, Tim Lautenschlaeger, Marvene Ewing, et al.Clinical Lung Cancer|July 11, 2025
In the Era of Neoadjuvant Chemoimmunotherapy, is There a Role for Radiation Intensification Therapy in Patients With Stage III (N2) Non-Small Cell Lung Cancer (NSCLC) Who Undergo Surgery? Results of LUN17-321 in the Context of Current Clinical Treatment OptionsMeagan Miller, Tim Lautenschlaeger, Thomas Birdas, et al.Molecular Biology International|April 25, 2012
Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder CancerWei Meng, Alexander Huebner, Ahmad Shabsigh, et al.Journal of the American Academy of Dermatology|January 11, 2018
Postdiagnosis aspirin use and overall survival in patients with melanomaSaleh Rachidi, Kristin Wallace, Hong Li, et al.Pageof 6